Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3692758017 | Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3692760015 | Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Is a | Benzocaine and salicylamide only product in cutaneous dose form | true | Inferred relationship | Some | ||
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Has BoSS | Salicylamide | true | Inferred relationship | Some | 1 | |
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Has BoSS | Benzocaine | true | Inferred relationship | Some | 2 | |
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Has precise active ingredient | Benzocaine | true | Inferred relationship | Some | 2 | |
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Has precise active ingredient | Salicylamide | true | Inferred relationship | Some | 1 | |
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Is a | Benzocaine-containing product | false | Inferred relationship | Some | ||
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Has active ingredient | Benzocaine | false | Inferred relationship | Some | ||
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Is a | Benzocaine- and salicylamide-containing product | false | Inferred relationship | Some | ||
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some | ||
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Has active ingredient | Salicylamide | false | Inferred relationship | Some | ||
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Has manufactured dose form | Gel | false | Inferred relationship | Some | ||
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Has manufactured dose form | Cutaneous gel | true | Inferred relationship | Some | ||
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Is a | Benzocaine in topical dosage form | false | Inferred relationship | Some | ||
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 2 | |
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Has precise active ingredient | Salicylamide | false | Inferred relationship | Some | 2 | |
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Has concentration strength numerator value | 20 | false | Inferred relationship | Some | 1 | |
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Has BoSS | Salicylamide | false | Inferred relationship | Some | 2 | |
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Has BoSS | Benzocaine | false | Inferred relationship | Some | 1 | |
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Has precise active ingredient | Benzocaine | false | Inferred relationship | Some | 1 | |
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Has concentration strength numerator value | 50 | false | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR